About this course
This program was developed to help oncology providers identify, evaluate, and manage patients at increased risk of hereditary cancer syndromes. The program was developed by the Michigan State Department of Health and Human Services and The Jackson Laboratory Clinical and Continuing Education Program with funding from the Centers for Disease Control and Prevention.
Genetic testing is becoming increasingly accessible for patients as the list of clinical indications and number of genes are growing, and the cost of testing is decreasing. Identifying a patient with an underlying genetic variant associated with cancer can impact his or her treatment options, long-term management approach, and risks for other cancer. In addition, there are implications for close family members. While genetic testing can provide important clinical information for decision-making, there are benefits, limitations, and risks. This program focuses on developing skills and knowledge to identify those patients most appropriate for genetic testing, choosing the right test, and using the results to develop a management plan.
Already enrolled? Access the course here.
.png)
No hay comentarios:
Publicar un comentario